Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 104830

In scope icon M 5 D
QID 104830 (Type "104830" in App Search)
A 65-year-old female with a history of rheumatoid arthritis presents to her primary care physician because she is concerned about her skin. She states that over the past few months she has become extremely itchy, in spite of applying numerous creams and lotions. She states that she has not noticed any visible changes or rashes on her skin and feels well apart from mild fatigue. On exam, the physician appreciates hepatosplenomegaly and observes the findings shown in Figure A. Laboratory testing reveals elevated antimitochondrial antibodies and a liver biopsy is obtained which is demonstrated in Figure B. What is the most likely underlying pathophysiology of this patient's disease?
  • A
  • B

Interlobular bile duct destruction

48%

10/21

Intra and extrahepatic bile duct fibrosis

29%

6/21

Extrahepatic bile duct obstruction

19%

4/21

Absent UDP-glucuronyl transferase

0%

0/21

Decreased bilirubin uptake

0%

0/21

  • A
  • B

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient presents with primary biliary cirrhosis (PBC), which is caused by autoimmune interlobular bile duct destruction.

PBC is an autoimmune condition in which interlobular bile ducts are destroyed. This causes the liver to be unable to excrete bile, causing a conjugated hyperbilirubinemia and elevated alkaline phosphatase. Patients with PBC tend to be female and present in middle age with an insidious onset of pruritus, jaundice, xanthelasma (Figure A), dark urine, light stools, and hepatosplenomegaly. PBC is associated with other autoimmune conditions such as CREST syndrome, rheumatoid arthritis, and celiac disease. On labs, elevated antimitochondrial antibodies are observed, and liver biopsy will show lymphocytic infiltrate and granulomas. The first line treatment for PBC is ursodeoxycholic acid which decreases symptoms and increases transplant-free survival time.

Roche and Kobos review the diagnosis and management of jaundice in the adult patient. They state that jaundice in an adult patient can be caused by a wide variety of benign or life-threatening disorders. Organizing the differential diagnosis by prehepatic, intrahepatic, and posthepatic causes may help make the work-up more manageable. The conjugated (direct) bilirubin level is often elevated by alcohol, infectious hepatitis, drug reactions, and autoimmune disorders such as PBC.

Dyson et al. examine novel therapeutic targets in PBC. They state that potential targets include the 'upstream' immune response, 'midstream' biliary injury, and 'downstream' fibrotic processes. Combination therapy targeting several pathways or the development of novel agents addressing multiple components of the disease pathway might be required.


Figure A demonstrates xanthelasma (yellowish deposit of fat underneath the skin), which is commonly observed in PBC. Figure B is a classic liver biopsy of PBC demonstrating lymphocytic infiltration and periductal inflammation. Illustration A is an immunofluorescent staining of the antimitochondrial antibodies observed in PBC. Illustration B demonstrates the pathophysiology of PBC.

Incorrect answers:
Answer 2: Intra- and extrahepatic bile duct fibrosis is observed in primary sclerosing cholangitis.
Answer 3: Extrahepatic bile duct obstruction is observed in secondary biliary cirrhosis caused by etiologies such as gallstones, biliary stricture, and carcinoma of the head of the pancreas.
Answer 4: Absent UDP-glucuronyl transferase is observed in Crigler-Najjar syndrome, type I, which produces an increased unconjugated bilirubin level and causes patients to die in the first few years of life.
Answer 5: Decreased bilirubin uptake cause Gilbert's syndrome, which causes an unconjugated bilirubinemia but otherwise has no clinical consequences.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

4.4

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(5)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options